Get my own profile
Public access
View all184 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Steven A RosenbergNCIVerified email at nih.gov
- Luca GattinoniLeibniz Institute for Immunotherapy (LIT)Verified email at lit.eu
- Christopher A. Klebanoff, M.D.Associate Member, Memorial Sloan Kettering Cancer CenterVerified email at mskcc.org
- Richard MorganCSO Be BiopharmaVerified email at be.bio
- Mark E DudleyCSO, Instil BioVerified email at instilbio.com
- Pawel MuranskiColumbia University Medical CenterVerified email at cumc.columbia.edu
- WILLEM W OVERWIJKNektar TherapeuticsVerified email at nektar.com
- Suzanne TopalianJohns Hopkins University School of MedicineVerified email at jhmi.edu
- Patrick HwuPresident and CEO, The Moffitt Cancer Center, Tampa, FLVerified email at moffitt.org
- Madhusudhanan sukumarJanssen PharmaceuticalsVerified email at ITS.JNJ.com
- Rahul RoychoudhuriUniversity of CambridgeVerified email at cam.ac.uk
- Steven E. Finkelstein, MD, DABR, FAC...Florida Cancer Affiliates / The US Oncology NetworkVerified email at usoncology.com
- Sid KerkarEXUMA BIOTECHVerified email at exumabio.com
- Zhili ZhengNational Cancer InstituteVerified email at mail.nih.gov
- Robert EilOregon Health & Science UniversityVerified email at ohsu.edu
- Suman VodnalaLyell ImmunopharmaVerified email at lyell.com
- Vincenzo BronteVerona University HospitalVerified email at univr.it
- Yutaka KawakamiKeio UniversityVerified email at keio.jp
- Jonathan YewdellLaboratory of Viral Diseases, NIAID, NIHVerified email at nih.gov
- Chyi-Chia Richard Lee, M.D., Ph.D.National Cancer Institute, National Institutes of HealthVerified email at mail.nih.gov